Faculty Opinions recommendation of Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture [dataset]

Yamini Dalal, Ankita Saha
2020 Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature   unpublished
A provided resources. W.B. and E.A. were involved in designing experiments. J.D.L. analyzed data and helped write manuscript. A.S. provided mouse model. T.S and S.P.L performed the in silico modeling. All authors contributed to the written manuscript. CONFLICT OF INTEREST A.M. has research funding from Janssen Pharmaceuticals and Daiichi Sankyo, has consulted for Epizyme and Constellation and is on the advisory board for KDAC Pharma. NLK is a consultant for Thermo Fisher Scientific. C.D.A is a
more » ... o-founder of Chroma Therapeutics and Constellation Pharmaceuticals, and a Scientific Advisory Board member of EpiCypher. EpiCypher is a commercial developer of the CUTANA® CUT&RUN platform. M.I. has received consultancy fees from Novartis Venture Fund outside of the scope of the work.
doi:10.3410/f.739178331.793581288 fatcat:sfj62i5u3ndw5nkzspzl2cujpi